Tag Archives: Bayh-Dole

Search on RE: Bayh-Dole provisions and subject inventions

Here’s a recent search on Research Enterprise: “bayh-dole provisions only apply to subject inventions.” Is it a question? Is it an assertion? Does Bayh-Dole apply only to subject inventions? No. Some Bayh-Dole provisions do apply to subject inventions, but much … Continue reading

Posted in Bayh-Dole | Tagged , , , | Leave a comment

The non-preference for US manufacturing under Bayh-Dole

A recent search at RE was looking for “preference for manufacturing in US under Bayh-Dole.” There’s a series of articles here on 35 USC 204. There’s also discussion of the related march-in provision at 35 USC 203(a)(4) and the broader … Continue reading

Posted in Bayh-Dole | Tagged , , , , | Leave a comment

Crap, crap, crap, Bayh-Dole, and crap talking points

Think of these as presentation slides, but without the actual mental pain of seeing slides. Bayh-Dole has failed to produce the outcomes claimed has destroyed university research freedom and technology transfer is a drafting nightmare of inconsistencies, half-hearted gestures, and … Continue reading

Posted in Bayh-Dole | Tagged , | Comments Off on Crap, crap, crap, Bayh-Dole, and crap talking points

Crap, crap, crap, Bayh-Dole, and crap (short attention span version)

Bayh-Dole is crap. Bayh-Dole practice is crap. Bayh-Dole outcomes are crap. Universities bluff about Bayh-Dole and about their metrics. Federal agencies don’t protect the public from university patent abuse. Federal agencies don’t act on the rights Bayh-Dole reserves for them. … Continue reading

Posted in Bayh-Dole | Tagged , | Comments Off on Crap, crap, crap, Bayh-Dole, and crap (short attention span version)

If you are against a crappy law like Bayh-Dole

Kevin E. Noonan, a biotech patent attorney, made an interesting assertion in a LinkedIn comment on the fourth article in this series. Maybe he was being flippant, but let’s consider: People against Bayh-Dole just support private industry (much of it … Continue reading

Posted in Bayh-Dole | Tagged , , , | Comments Off on If you are against a crappy law like Bayh-Dole

Reflections on Shill Reflections on Bayh-Dole, 4: Fake history, executive branch patent policy, and contamination

Back to reflecting on fake history, namely this: prior to the Act, the government often funded research to spark innovation, but then put the research in the public domain for non-exclusive licensing,… Executive branch patent policy from Kennedy on (until … Continue reading

Posted in Bayh-Dole, History, Policy | Tagged , , , | Comments Off on Reflections on Shill Reflections on Bayh-Dole, 4: Fake history, executive branch patent policy, and contamination

Reflections on Shill Reflections on Bayh-Dole, 3: Fake history, sparking innovation, and a pernicious requirement

[I have made revisions and additions and placed the second half of this article in part 4.] We are still reflecting on reflections on Bayh-Dole by “leaders” hoping that you will follow them. More: prior to the Act, the government … Continue reading

Posted in Bayh-Dole, Policy | Tagged , , , , | Comments Off on Reflections on Shill Reflections on Bayh-Dole, 3: Fake history, sparking innovation, and a pernicious requirement

Reflections on Shill Reflections on Bayh-Dole, 2: Commercialization and certainty

We are working through reflections of Bayh-Dole made by some iron rings in cows’ noses that claim to give milk–er, “industry leaders.” The exercise is useful not merely to mock them for their nonsense–mockery is here salutory and inclusive–but also … Continue reading

Posted in Bayh-Dole, Policy | Tagged , , | Comments Off on Reflections on Shill Reflections on Bayh-Dole, 2: Commercialization and certainty

Reflections on Shill Reflections on Bayh-Dole, 1: Intent and utilization

Rebecca Tapscott has posted an article at IP Watchdog, “Industry Leaders Reflect on Bayh-Dole at 40.” There are lots of problems with this article–and with the “leaders’” “reflections” when it comes to Bayh-Dole. But hey, folks are entitled to mis-remember … Continue reading

Posted in Bayh-Dole, History, Technology Transfer | Tagged , , , | Comments Off on Reflections on Shill Reflections on Bayh-Dole, 1: Intent and utilization

The Wall Street Journal publishes an editorial against using Bayh-Dole march-in for remdesivir

Sally Pipes has published an op/ed piece at the Wall Street Journal on Bayh-Dole and Gilead, “The Remdesivir Patent Isn’t State Property.” There is so much going on with Pipes’s work. We should take a closer look. First, the title … Continue reading

Posted in Bayh-Dole, high priced medicines, Policy | Tagged , , , | Comments Off on The Wall Street Journal publishes an editorial against using Bayh-Dole march-in for remdesivir